Sec Form 4 Filing - Bardwell Kathleen @ Steris plc - 2017-01-17

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Bardwell Kathleen
2. Issuer Name and Ticker or Trading Symbol
Steris plc [ STE]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Sr.V. P. & C.C.O.
(Last) (First) (Middle)
C/O CHANCERY HOUSE, 190 WATERSIDE RD., HAMILTON INDUSTRIAL PARK
3. Date of Earliest Transaction (MM/DD/YY)
01/17/2017
(Street)
LEISCESTER, X0LE5 1QZ
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares, 0.10 par value 01/17/2017 M 962 ( 1 ) A $ 22.83 16,538 D
Ordinary Shares, 0.10 par value 01/17/2017 M 1,000 ( 2 ) A $ 34.23 17,538 D
Ordinary Shares, 0.10 par value 01/17/2017 S 1,962 D $ 68.78 15,576 ( 3 ) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $ 22.83 01/17/2017 M 962 ( 4 ) 05/21/2019 Ordinary Shares 962 ( 4 ) 0 D
Employee Stock Option (right to buy) $ 34.23 01/17/2017 M 1,000 ( 5 ) 11/12/2019 Ordinary Shares 1,000 ( 5 ) 0 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Bardwell Kathleen
C/O CHANCERY HOUSE, 190 WATERSIDE RD.
HAMILTON INDUSTRIAL PARK
LEISCESTER, X0LE5 1QZ
Sr.V. P. & C.C.O.
Signatures
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney 01/18/2017
Signature of Reporting Person Date
Explanation of Responses:
( 1 )This exercise and sale of a total of 962 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 15, 2016.
( 2 )This exercise and sale of a total of 1,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on November 15, 2016.
( 3 )6,950 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 500 on June 1, 2017; 500 on June 1, 2018; 500 on June 3, 2019; 500 on June 1, 2020; 625 on May 30, 2017; 625 on May 28, 2018; 625 on May 28, 2019; 750 on May 30, 2017; 750 on May 30, 2018; 450 on May 31, 2017; 375 on October 2, 2017; 375 on October 1, 2018 and 375 on October 1, 2019.
( 4 )This option to purchase 962 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 962 STERIS Corporation common shares for $22.83 per share, subject to the same terms and conditions as the original STERIS Corporation stock option.
( 5 )This option to purchase 1,000 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 1,000 STERIS Corporation common shares for $34.23 per share, subject to the same terms and conditions as the original STERIS Corporation stock option.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.